IDGXF Company Profile and Key Details

Q: Who are the executives of IDGXF?

Dr. Hend El SherbiniGroup Chief Executive Officer & Executive DirectorDr. Seham IbrahimSales DirectorMr. Mohamed Kamel SalehGen. CounselDr. Osama S. ZaghloulManaging Director of UltralabNancy FahmyInvestor Relations DirectorDr. Eissa KhorshidChief Operating OfficerDr. Amid AbdelnourManaging Director of BiolabDr. Moushira El SaifiHead of Hematology DepartmentDr. Mohamed Akram Abdel-Rahman NouhHead of Pathology Department and Information Technology AdministratorMr. Omar BedewyGroup Chief Financial Officer and Vice President of Fin. & Strategies

PNK : IDGXF

Integrated Diagnostics

$0.31

0.012+4.05%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Integrated Diagnostics Holdings plc (IDGXF) stock surged +11.44%, trading at $0.55 on OTC, up from the previous close of $0.49. The stock opened at $0.55, fluctuating between $0.55 and $0.55 in the recent session.

Stock Snapshot

0.4947

Prev. Close

320.49M

Market Cap

0.5513

Day Low

16.23

P/E Ratio

0.03397

EPS (TTM)

0.48

Cash Flow per Share

0.55

Open

581.33M

Number of Shares

0.5513

Day High

52.07%

Free Float in %

4.46

Book Value

2.8K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 28, 2026	0.55	0.55	0.55	0.55	2.8K
Jun 30, 2026	0.49	0.49	0.49	0.49	4.32K
Jun 29, 2026	0.49	0.49	0.49	0.49	3K
Jun 16, 2026	0.58	0.58	0.58	0.58	200
May 05, 2026	0.59	0.59	0.59	0.59	937
Feb 17, 2026	0.64	0.64	0.64	0.64	900
Jan 14, 2026	0.68	0.68	0.68	0.68	500
Dec 19, 2025	0.68	0.68	0.68	0.68	1.51K
Dec 03, 2025	0.70	0.70	0.70	0.70	500
Dec 01, 2025	0.63	0.63	0.63	0.63	1K
Nov 17, 2025	0.65	0.65	0.65	0.65	100
Oct 29, 2025	0.51	0.51	0.51	0.51	650
Oct 27, 2025	0.54	0.54	0.53	0.53	6K
Oct 09, 2025	0.45	0.45	0.45	0.45	200
Oct 06, 2025	0.50	0.50	0.50	0.50	5K
Oct 03, 2025	0.54	0.54	0.54	0.54	10K
Sep 18, 2025	0.48	0.48	0.48	0.48	0
Sep 15, 2025	0.48	0.48	0.48	0.48	0
Sep 11, 2025	0.48	0.48	0.48	0.48	0
Sep 08, 2025	0.48	0.48	0.48	0.48	130

Contact Details

Saint Helier, GZ JE2 3RT

Jersey

https://www.idhcorp.com 441 534 847000

About Company

Integrated Diagnostics Holdings plc (IDGXF) functions as a consumer-focused healthcare enterprise, primarily dedicated to providing a comprehensive array of medical diagnostic services for patients. Its extensive service portfolio encompasses approximately 2,000 distinct diagnostic examinations, spanning diverse fields such as immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company maintains an operational footprint across Egypt, Jordan, Sudan, and Nigeria. By December 30, 2021, its network had grown to encompass 452 branch laboratories. Established in 1979, the organization's main office is situated in Saint Helier, Jersey.

Stock Peers

LZAGF

-5-0.92%

Lonza Group AG$541.00 ERFSF

Eurofins Scientific SE$60.50 OPGN

9.75+64.36%

OpGen, Inc.$23.91 SKHHY

-0.03-0.18%

Sonic Healthcare Limited$16.77 SKHCF

Sonic Healthcare Limited$16.20 WUXAY

0.04+0.87%

WuXi AppTec Co., Ltd.$4.62 PCHM

PharmChem, Inc.$3.13 ANPCY

ANGLE plc$2.39 IDXG

-0.11-8.03%

Interpace Biosciences, Inc.$1.26 IBXXF

0.232+966.67%

Imagion Biosystems Limited$0.26

Company Overview

Integrated Diagnostics Holdings plc (OTC:IDGXF) closed at $0.55 USD, gaining $0.06 (11.44%) from the previous close of $0.49. The stock is currently mid-range between its 52-week high and low $0.32 and $0.70. With a market capitalization of about $320.49 million, Integrated Diagnostics Holdings plc is classified as a small-cap and shows lower-than-market volatility (beta ~0.40). Key stats such as the average daily volume over the past year has been around 138.00 shares, trading with heavier-than-usual volume. Headquartered in Saint Helier, GZ, Integrated Diagnostics Holdings plc operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Hend El Sherbini, the company employs approximately 6,309 people and listed since June 03, 2019. Integrated Diagnostics Holdings plc (IDGXF) functions as a consumer-focused healthcare enterprise, primarily dedicated to providing a comprehensive array of medical diagnostic services for patients.

Technical Performance

Average 10-day trading volume of 2.80 thousand shares is slightly above the 3-month average of 2.25 thousand, indicating heightened recent market interest.

Valuation Metrics

Integrated Diagnostics Holdings plc trades at a P/E ratio of 10.8, slightly below the S&P 500 average, with a price-to-sales ratio of 1.85 and a price-to-book ratio of 3.65 trading at moderately above to book value. The P/FCF stands at 107.14, also above market averages.

Dividend & Fair Value

Integrated Diagnostics Holdings plc last paid a dividend of 0.03 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.78. This means the shares are trading below this model’s fair value.

Financial & Profitability Overview

Over the trailing twelve months, Integrated Diagnostics generated $4.12B in revenue, or $6.87 per share. Gross margin was 36.98%, operating margin 17.90%, and net profit margin 12.38%. Returns are healthy, with ROA at 8.84% and ROE at 19.05%.
On valuation metrics, Integrated Diagnostics trades at a P/E of 10.80, P/S of 1.85 and P/B of 3.65.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Integrated Diagnostics posted revenue of $4.12B, down slightly from $3.61B in the prior quarter. Gross profit was $1.52B (margin 36.98%). Operating income was $737.76M (margin 17.9%). Net income was$510.30M (EPS $0.85).
The company ended the quarter with $860.51M in cash and short-term investments, a total debt of $1.18B, and net debt of $504.95M. Total assets were $5.77B, with equity of $3.10B. Financials further reflected stability, with operating cash flow of $543.66M, free cash flow of $217.73M, and capital expenditures of - $325.93M.

Price Forecast & Outlook

Our AI price prediction model suggests that Integrated Diagnostics Holdings plc stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

Valuation shows Integrated Diagnostics Holdings plc trading at a premium to the broader market with a P/E of 10.8.

Frequently Asked Questions

What is the current Integrated Diagnostics Holdings plc (IDGXF) stock price?

Integrated Diagnostics Holdings plc (OTC: IDGXF) stock price is $0.55 in the last trading session. During the trading session, IDGXF stock reached the peak price of $0.55 while $0.55 was the lowest point it dropped to. The percentage change in IDGXF stock occurred in the recent session was 11.44% while the dollar amount for the price change in IDGXF stock was $0.06.

IDGXF's industry and sector of operation?

The OTC listed IDGXF is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. Integrated Diagnostics Holdings plc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IDGXF?

Dr. Hend El Sherbini
Group Chief Executive Officer & Executive Director
Dr. Seham Ibrahim
Sales Director
Mr. Mohamed Kamel Saleh
Gen. Counsel
Dr. Osama S. Zaghloul
Managing Director of Ultralab
Nancy Fahmy
Investor Relations Director
Dr. Eissa Khorshid
Chief Operating Officer
Dr. Amid Abdelnour
Managing Director of Biolab
Dr. Moushira El Saifi
Head of Hematology Department
Dr. Mohamed Akram Abdel-Rahman Nouh
Head of Pathology Department and Information Technology Administrator
Mr. Omar Bedewy
Group Chief Financial Officer and Vice President of Fin. & Strategies

How IDGXF did perform over past 52-week?

IDGXF's closing price is 11.96% higher than its 52-week low of $0.32 where as its distance from 52-week high of $0.70 is -46.99%.

How many employees does IDGXF have?

Number of IDGXF employees currently stands at 6,309.

Link for IDGXF official website?

Official Website of IDGXF is: https://www.idhcorp.com

How do I contact IDGXF?

IDGXF could be contacted at phone 441 534 847000 and can also be accessed through its website. IDGXF operates from 12 Castle Street, Saint Helier, GZ JE2 3RT, Jersey.

How many shares of IDGXF are traded daily?

IDGXF stock volume for the day was 2.8K shares. The average number of IDGXF shares traded daily for last 3 months was 138.

What is the market cap of IDGXF currently?

The market value of IDGXF currently stands at $320.49M with its latest stock price at $0.55 and 581.33M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	6309
Beta	0.4
Sales or Revenue	$4.12B
5Y Sales Change%	1.146%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Diagnostics & Research

IDGXF Company Profile and Key Details

Integrated Diagnostics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Key Takeaways

Price Forecast & Outlook

Valuation Metrics